These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 31005226)

  • 41. Feasibility of delivered dose reconstruction for MR-guided SBRT of pancreatic tumors with fast, real-time 3D cine MRI.
    Grimbergen G; Pötgens GG; Eijkelenkamp H; Raaymakers BW; Intven MPW; Meijer GJ
    Radiother Oncol; 2023 May; 182():109506. PubMed ID: 36736589
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Phase I trial of stereotactic MR-guided online adaptive radiation therapy (SMART) for the treatment of oligometastatic or unresectable primary malignancies of the abdomen.
    Henke L; Kashani R; Robinson C; Curcuru A; DeWees T; Bradley J; Green O; Michalski J; Mutic S; Parikh P; Olsen J
    Radiother Oncol; 2018 Mar; 126(3):519-526. PubMed ID: 29277446
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intrafractional relationship changes between an external breathing signal and fiducial marker positions in pancreatic cancer patients.
    Pettersson N; Oderinde OM; Murphy J; Simpson D; Cerviño LI
    J Appl Clin Med Phys; 2020 Mar; 21(3):153-161. PubMed ID: 32170900
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Accumulated dose in liver stereotactic body radiotherapy: positioning, breathing, and deformation effects.
    Velec M; Moseley JL; Craig T; Dawson LA; Brock KK
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1132-40. PubMed ID: 22208969
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Functional image-guided stereotactic body radiation therapy planning for patients with hepatocellular carcinoma.
    Tsegmed U; Kimura T; Nakashima T; Nakamura Y; Higaki T; Imano N; Doi Y; Kenjo M; Ozawa S; Murakami Y; Awai K; Nagata Y
    Med Dosim; 2017 Summer; 42(2):97-103. PubMed ID: 28433483
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Is SBRT Boost Feasible for PET Positive Lymph Nodes for Cervical Cancer? Evaluation using Tumor Control Probability and QUANTEC Criteria.
    Snyder JE; Willett AB; Sun W; Kim Y
    Pract Radiat Oncol; 2019 Mar; 9(2):e156-e163. PubMed ID: 30415074
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adaptive stereotactic body radiation therapy planning for lung cancer.
    Qin Y; Zhang F; Yoo DS; Kelsey CR; Yin FF; Cai J
    Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):209-15. PubMed ID: 23790773
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Clinical and Dosimetric Impact of Real-Time Target Tracking in Pancreatic SBRT.
    Vinogradskiy Y; Goodman KA; Schefter T; Miften M; Jones BL
    Int J Radiat Oncol Biol Phys; 2019 Jan; 103(1):268-275. PubMed ID: 30145394
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sparing the surgical area with stereotactic body radiotherapy for combined treatment of spinal metastases: a treatment planning study.
    Versteeg AL; Hes J; van der Velden JM; Eppinga W; Kasperts N; Verkooijen HM; van Vulpen M; Oner FC; Seravalli E; Verlaan JJ
    Acta Oncol; 2019 Feb; 58(2):251-256. PubMed ID: 30513233
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of various online strategies to account for interfractional variations for pancreatic cancer.
    Ahunbay EE; Kimura B; Liu F; Erickson BA; Li XA
    Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):914-21. PubMed ID: 23845843
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Helical tomotherapy-based STAT stereotactic body radiation therapy: Dosimetric evaluation for a real-time SBRT treatment planning and delivery program.
    Dunlap N; McIntosh A; Sheng K; Yang W; Turner B; Shoushtari A; Sheehan J; Jones DR; Lu W; Ruchala K; Olivera G; Parnell D; Larner JL; Benedict SH; Read PW
    Med Dosim; 2010; 35(4):312-9. PubMed ID: 21055611
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Simulated dose painting of hypoxic sub-volumes in pancreatic cancer stereotactic body radiotherapy.
    Elamir AM; Stanescu T; Shessel A; Tadic T; Yeung I; Letourneau D; Kim J; Lukovic J; Dawson LA; Wong R; Barry A; Brierley J; Gallinger S; Knox J; O'Kane G; Dhani N; Hosni A; Taylor E
    Phys Med Biol; 2021 Sep; 66(18):. PubMed ID: 34438383
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of On-Table Plan Adaptation in MR-Guided Ablative Radiation Therapy for Central Lung Tumors.
    Finazzi T; Palacios MA; Spoelstra FOB; Haasbeek CJA; Bruynzeel AME; Slotman BJ; Lagerwaard FJ; Senan S
    Int J Radiat Oncol Biol Phys; 2019 Jul; 104(4):933-941. PubMed ID: 30928360
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dosimetric analysis of organs at risk during expiratory gating in stereotactic body radiation therapy for pancreatic cancer.
    Taniguchi CM; Murphy JD; Eclov N; Atwood TF; Kielar KN; Christman-Skieller C; Mok E; Xing L; Koong AC; Chang DT
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):1090-5. PubMed ID: 23273994
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Optimization of stereotactic body radiotherapy treatment planning using a multicriteria optimization algorithm.
    Ghandour S; Cosinschi A; Mazouni Z; Pachoud M; Matzinger O
    Z Med Phys; 2016 Dec; 26(4):362-370. PubMed ID: 27156924
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fast and robust adaptation of organs-at-risk delineations from planning scans to match daily anatomy in pre-treatment scans for online-adaptive radiotherapy of abdominal tumors.
    Gupta V; Wang Y; Méndez Romero A; Myronenko A; Jordan P; Maurer C; Heijmen B; Hoogeman M
    Radiother Oncol; 2018 May; 127(2):332-338. PubMed ID: 29526492
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of rotational errors in treatment setup of stereotactic body radiation therapy of liver cancer.
    Cao M; Lasley FD; Das IJ; Desrosiers CM; Slessinger ED; Cardenes HR
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):e435-40. PubMed ID: 22727886
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dosimetric evaluation of simultaneous integrated boost during stereotactic body radiation therapy for pancreatic cancer.
    Yang W; Reznik R; Fraass BA; Nissen N; Hendifar A; Wachsman A; Sandler H; Tuli R
    Med Dosim; 2015; 40(1):47-52. PubMed ID: 25445989
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dosimetric and radiobiological comparison of treatment plan between CyberKnife and EDGE in stereotactic body radiotherapy for pancreatic cancer.
    Dai ZT; Ma L; Cao TT; Zhu L; Zhao M; Li N
    Sci Rep; 2021 Feb; 11(1):4065. PubMed ID: 33603030
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Plan quality improvement by DVH sharing and planner's experience: Results of a SBRT multicentric planning study on prostate.
    Villaggi E; Hernandez V; Fusella M; Moretti E; Russo S; Vaccara EML; Nardiello B; Esposito M; Saez J; Cilla S; Marino C; Stasi M; Mancosu P
    Phys Med; 2019 Jun; 62():73-82. PubMed ID: 31153401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.